Genomics Medicine Ireland Opens Dublin Clinic for Precision Medicine Research

Genomics Medicine Ireland (GMI), the recently-acquired Irish subsidiary of WuXi NextCode, said today it has opened a research clinic in Dublin’s City Centre hub,...
Prostate cancer cells, illustration

Helomics, SpeciCare Enter Live Tumor Tissue Precision Cancer Care Collaboration

Helomics will provide CRO services and its D-CHIP artificial intelligence (AI) platform for a functional precision medicine study called PIONEER sponsored by SpeciCare.
Source: freestylephoto/Getty Images

20 Molecular Diagnostics Companies to Watch

Up-and-Coming Diagnostic Test Developers Emerge as Consolidation Thins the Field.

Genomics England Reports Positive First Phase of Cancer ctDNA Study

Genomics England said it has generated positive results from the first phase of a collaboration with Inivata and Thermo Fisher Scientific designed to study...

PerkinElmer, Helix Partner to Launch Genetic Screening Test

The DNA test available to healthy individuals analyzes all 59 medically actionable genes identified by the American College of Medical Genetics and Genomics.
Source: Martin Barraud/Getty Images

10 Countries in 100K Genome Club

These ten governments have committed funding for projects that will sequence a minimum of 100,000 citizens to spur genomic medicine
Source: Melitios Verros/Getty Images

Mammoth Competition: Feng Zhang, Partners Launch CRISPR Dx Company

Company will leverage synthetic biology and CRISPR patents held by the Broad Institute and Harvard's Wyss Institute to create next-gen MDxes

ArcherDx, UCL Collaborate on ctDNA Lung Cancer Study

The collaboration with the University College London (UCL) and the Francis Crick Institute will use ArcherDX's proprietary Anchored Multiplex PCR (AMP) technology to detect evidence of disease recurrence in lung cancer patients using cell-free circulating tumor DNA (ctDNA) as part of the UCL-sponsored TRACERx clinical study.

Exclusive: A Conversation with David Bentley, VP and Chief Scientist, Illumina

From Guy's Hospital in London and the Sanger Centre during the Human Genome Project to one of the first to join early sequencing company Solexa and its subsequent acquisition by Illumina, David Bentley has seen clinical genomics come full circle.
Ambry Genetics and My Gene Counsel said they will partner to offer medical-grade testing designed to confirm results of direct-to-consumer (DTC) genetic tests

Ambry and My Gene Counsel Team Up on Tests to Confirm DTC Results, Counseling

Program designed for consumers who have taken a DTC genetic test, have a personal or family history of cancer and have unresolved questions.
Scroll Up